Wells Fargo becomes bullish on this biotech company
Neurocrine Biosciences ‘ drug pipeline is turning a corner and the company will be “knocking on the doors of the large-cap club” soon, according to Wells Fargo. Analyst Mohit Bansal …
Neurocrine Biosciences Inc
Innovation and M&A to boost these stocks
There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall, 12 mental health disorders affect 970 million people around the world â or one …
These tenbagger stocks are well liked by analysts and may rally more
Over the last 10 years of market turbulence, there haven’t been very many stocks that have seen a more than 1,000% compound return. Fewer still of these “tenbaggers,” companies that …